OMTX-705 is under clinical development by Oncomatryx Biopharma and currently in Phase I for Esophageal Cancer.

Recombinant antibody technology has helped address many problems associated with hybridoma platforms, opening the door to a ...

Sutro Biopharma, a drug development and manufacturing ... natural amino acids (nnAAs), which together allow for the precise design and rapid expression of homogeneous therapeutic bioconjugates ...

How to Implement an Effective Cleanroom Monitoring System In light of these potential problems, biopharma companies should ...

Yet, the biopharma industry’s ability to extract ... bring its breakthroughs to healthcare providers. The idea is to design tools that unlock imaging data to improve patient outcomes.

ESG considerations, outlooks in the overall industry, therapeutic areas, and drug pricing, and more. Get the full report to discover which biopharma stocks will benefit your clients’ portfolios.

ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. The firm's product pipeline includes ABV-1501, which is a ...

This page provides educational resources, events, news and products related to vaccine design and testing. Content will cover aspects from identifying vaccine targets, developing a vaccine and ...

Fintel reports that on December 24, 2024, LifeSci Capital initiated coverage of Mereo BioPharma Group plc - Depositary ...

Justin Walsh, an analyst from JonesTrading, reiterated the Buy rating on Vor Biopharma (VOR – Research Report). The associated price target remains the same with $18.00. Justin Walsh has given ...

The regulatory agency charged Kiromic Biopharma and its former CEO and CFO for their roles in disclosures related to drug candidates' FDA status. Regulators have agreed to settle charges against a ...